Related Experiment Video
Updated: May 10, 2025

05:51
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
Published on: October 14, 2021
3.6K
Data-Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness
Jian-Yong Wang1, Guo-Ling Zeng1, Rong-Ting Tang2
1Department of Neurology and Institute of Geriatric Neurology, The Second Affiliated Hospital and Yuying Children's Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, China.
CNS Neuroscience & Therapeutics
|April 24, 2025
Summary
Researchers identified four Parkinson disease (PD) subtypes based on how patients respond to dopamine medication. This discovery aids in understanding PD
Area of Science:
- Neurology
- Pharmacology
- Movement Disorders
Background:
- Parkinson disease (PD) exhibits significant variability in patient response to antiparkinsonian medications.
- Understanding this heterogeneity is crucial for developing effective treatment strategies.
Purpose of the Study:
- To identify distinct Parkinson disease (PD) subtypes based on dopamine responsiveness.
- To analyze dopamine responsiveness across three cardinal motor signs: resting tremor, rigidity, and bradykinesia.
Main Methods:
- Utilized the acute levodopa challenge test in 228 PD patients.
- Calculated improvement rates for resting tremor, rigidity, and bradykinesia.
- Employed k-means clustering to define subtypes based on observed improvement rates.
Main Results:
- Identified four distinct PD subtypes based on levodopa response patterns.
- Subtypes demonstrated varied levels of improvement in resting tremor, rigidity, and bradykinesia.
- These subtypes also exhibited differences in other motor and non-motor symptoms.
Conclusions:
- The study successfully delineated four unique Parkinson disease subtypes characterized by dopamine responsiveness.
- These findings offer new insights into PD heterogeneity.
- The identified subtypes can potentially facilitate personalized treatment approaches for Parkinson disease.
Related Concept Videos
Parkinson's Disease: Treatment
148
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
148
Parkinson's Disease: Overview
310
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
310
Neural Regulation
39.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.0K
EPS and iPS Cells in Disease Research
2.7K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
2.7K

